Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance)
利用放射组学特征评估索拉非尼治疗晚期肝细胞癌患者的生存期:癌症和白血病 B 组 80802(联盟)
期刊:ESMO Open
影响因子:8.3
doi:10.1016/j.esmoop.2025.105848
Dercle, L; Geyer, S; Nixon, A B; Innocenti, F; Shi, Q; Jacobson, S B; Luk, L; Liu, A; Yang, H; Wen, Y; Zhao, B; Eche, T; Mokrane, F-Z; Yang, M; Meyerhardt, J; O'Reilly, E M; Venook, A P; El-Khoueiry, A B; Schwartz, L H; Abou-Alfa, G K